Rare diseases
Investigational molecules
Locations
Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis
AustriaZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
BulgariaICP-332 for Adults with Prurigo Nodularis
AustriaLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
BelgiumBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
BulgariaA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
CzechiaA study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis
BelgiumA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
CzechiaPhase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury
DenmarkA study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis
BulgariaA study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis
BulgariaA study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
